Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03592186 · ClinicalTrials.gov registry record · NA

Adolescents With Substance Use Disorders Transitioníng From Residential Treatment to the Community

A NA study of Substance Use and Adolescent Behavior, sponsored by Brown University.

Completed
Registry status
NA
Development phase
122
Enrollment target
2
Study locations

NCT03592186: Completed NA study of Substance Use and Adolescent Behavior, sponsored by Brown University.

NCT03592186 is a NA study of Substance Use and Adolescent Behavior that has completed, run by Brown University. The registered enrollment target is 122 participants, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03592186, a NA study of Substance Use and Adolescent Behavior, has completed, sponsored by Brown University.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target
2
Study locations

Study Summary

Adolescents with substance use disorders (ASUD) in residential treatment have the most serious substance use disorders and the highest rates of psychological, motivational, behavioral, legal, environmental, and vocational problems. ASUD in residential treatment are also at high risk of relapse, with follow-up studies suggesting that 60% of ASUD will relapse within 90 days of discharge. Parenting practices have been established as a key influence on adolescents' initiation and maintenance of substance use, as well as their substance use outcomes and likelihood of relapse. However, therapists who treat ASUD have reported a myriad of systemic barriers to engaging parents in treatment. Findings such as these deem ASUD in residential treatment a high priority population and argue for the value of easily accessible parenting interventions during this critical time. The proposed study evaluates a low cost, low intensity model for delivering parenting skills to parents preparing for their adolescent's discharge from residential substance use (SU) treatment. Specifically, this project involves adapting the delivery of a computerized parenting intervention (Parenting Wisely; PW) that has preliminary evidence of efficacy in improving parenting skills and reducing youth behavior problems. This study adapts the delivery of PW for a new population (parents of ASUD) and new setting (residential treatment), and obtains initial data on its feasibility, acceptability, and effectiveness. As a first step, an open trial with 10 parents was conducted to develop and pilot an adapted version of PW that included moderate engagement strategies: in-person coaching sessions, daily text messages containing reminders of parenting skills and links to video vignettes, and an online parent forum containing two networking boards (Ask an Expert and Connect with Parents). In the current phase, a pilot randomized trial with 60 parents will compare an adapted PW plus treatment as usual (TAU) condition (

Primary Outcome

Global Appraisal of Individual Needs - Quick Version (GAIN-Q3) is a well-validated substance use screening tool used to assess adolescent substance use in a range of settings. Substance consumption information is collected using a calendar format with temporal cues (e.g., holidays) to assist in recall of days when alcohol and other drugs were used. Possible number of days range from 0 to 90. Values are adjusted to reflect the proportion of days used outside of controlled environment, with final

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL Parenting Wisely+

Study Locations (2)

Illinois

  • Rosecrance Health Network - Rockford

Rhode Island

  • Caritas ARTS Program - Cranston

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2017-04-01
Est. Completion 2020-02-28
Phase NA
Brown University

231 total trials

What the finished NCT03592186 record still lists

NCT03592186 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (90% lower).

The record links to 2 conditions, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT03592186 reports a single indexed study location in Illinois, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT03592186 about?

NCT03592186 is a clinical study titled "Adolescents With Substance Use Disorders Transitioníng From Residential Treatment to the Community". Adolescents with substance use disorders (ASUD) in residential treatment have the most serious substance use disorders and the highest rates of psychological, motivational, behavioral, legal, environmental, and vocational problems. ASUD in residential treatment are also at high risk of relapse, with...

What is the current status of trial NCT03592186?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2017-04-01. Estimated completion is 2020-02-28.

What conditions does trial NCT03592186 study?

This clinical trial studies the following conditions: Substance Use, Adolescent Behavior.

What interventions are being tested in trial NCT03592186?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Parenting Wisely+ (BEHAVIORAL).

Who is sponsoring clinical trial NCT03592186?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03592186 being conducted?

This trial has 2 study locations across Illinois, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03592186's enrollment target sits among peer trials

122 57th of 88 higher than 32 of 88 other Substance Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03363373 · 122 participants · Phase 2

    Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

  • NCT03463954 · 122 participants · NA

    Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

  • NCT04503265 · 122 participants · Phase 1

    A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

  • NCT04700527 · 122 participants · Phase 1

    The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03592186, the US trial registry maintained by the National Library of Medicine. NCT03592186 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.